Related Experiment Video
Updated: Jun 12, 2026

Fully Processed Recombinant KRAS4b: Isolating and Characterizing the Farnesylated and Methylated Protein
Published on: January 16, 2020
Expression, purification, and characterization of soluble K-Ras4B for structural analysis
Sherwin J Abraham1, Ismaeel Muhamed, Ryan Nolet
1Department of Biochemistry and Molecular Genetics, University of Illinois at Chicago, Chicago, IL 60607, United States.
Abstract:
A p21 GTPase K-Ras4B plays an important role in human cancer and represents an excellent target for cancer therapeutics. Currently, there are no drugs directly targeting K-Ras4B. In part, this is due to the lack of structural information describing unique features of K-Ras4B. Here we describe a methodology allowing production of soluble, well-folded K-Ras4B for structural analysis. The key points in K-Ras4B preparation are low temperature expression and extraction of K-Ras4B from the insoluble fraction using a nucleotide loading procedure in the presence of Mg(2+) and citrate, a low affinity chelator. Additionally, a significant amount of K-Ras4B could be extracted from the soluble fraction. We show that recombinant K-Ras4B is monomeric in solution. Excellent NMR signal dispersion suggests that the protein is well-folded and is amenable to solution structure determination. In addition, using phospholipid bilayer nanodiscs we show that recombinant K-Ras4B interacts with lipids and that this interaction is mediated by the C-terminal hypervariable region.
Insights
Researchers developed a method to produce soluble, well-folded K-Ras4B protein for structural studies. This breakthrough aids in developing targeted cancer therapies by revealing K-Ras4B
Area of Science:
- Biochemistry
- Structural Biology
- Cancer Research
Background:
- K-Ras4B, a p21 GTPase, is crucial in human cancers.
- Targeting K-Ras4B is a promising therapeutic strategy.
- Lack of structural data hinders K-Ras4B drug development.
Purpose of the Study:
- To develop a method for producing soluble, well-folded K-Ras4B.
- To enable structural analysis of K-Ras4B.
- To investigate K-Ras4B's interaction with lipids.
Main Methods:
- Low-temperature expression and extraction of K-Ras4B.
- Nucleotide loading with Mg(2+) and citrate.
- Phospholipid bilayer nanodiscs for lipid interaction studies.
Main Results:
- Successfully produced soluble, well-folded recombinant K-Ras4B.
- Confirmed K-Ras4B is monomeric in solution.
- Demonstrated K-Ras4B lipid interaction via its C-terminal hypervariable region.
Conclusions:
- The developed methodology facilitates K-Ras4B structural determination.
- Structural insights can guide the development of K-Ras4B-targeted cancer therapeutics.
- K-Ras4B's lipid interaction is a key functional aspect.
Related Concept Videos
The Ras Gene
Ras is a superfamily...
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
